Our finding of its reduced expression in STCs vs LTCs is intriguing as it suggests that in glioblastoma too it may play a role similar to that performed in breast cancer, in the context of TGFβ-modulated pathways. This evidence concerns the gene TGFB1 and glioblastoma.